EUVIMEDEUVIMED entdecken
Crossref

Subtype‐specific immunophenotypic and cytogenetic patterns complement flow‐cytometric detection of measurable residual disease in B‐lymphoblastic leukemia

Ju-Hyeong Lee iD, Tae-Shin Kim iD, Sang Mee Hwang iD, Hyungsuk Kim iD, Yoon Hwan Chang iD, Hyun Kyung Kim iD, Seon Young Kim iD

Cytometry Part B: Clinical Cytometry · 08.08.2026

DOI: 10.1002/cyto.b.70062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, online erschienen am 08.08.2026. Verfasst von Ju-Hyeong Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Die Arbeit nennt 43 Literaturangaben. Gefördert von: SNUH Research Fund, Korean Society of Hematology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Measurable residual disease (MRD) is a key prognostic marker in B‐lymphoblastic leukemia (B‐ALL). Because immunophenotypic and cytogenetic features vary by genetic subtype and treatment phase, the clinical value of an integrated MRD strategy using multiparametric flow cytometry (MFC), fluorescence in situ hybridization (FISH), and immunoglobulin clonality next‐generation sequencing (NGS) warrants evaluation. This retrospective single‐center study included 136 patients with B‐ALL and 491 bone marrow MRD assessments. MRD was evaluated by an 8‐color MFC panel adapted from the modified EuroFlow protocol, targeted FISH probes with an exploratory integrated interpretation for low‐level signals, and IGH/IGK NGS. Immunophenotypic marker expression and associations with genetic subtypes were analyzed in MFC MRD‐positive samples. MRD levels were significantly correlated across modalities: MFC–FISH ( ρ = 0.762), MFC–NGS ( ρ = 0.674), and FISH–NGS ( ρ = 0.341). Using NGS as the molecular comparator, MFC showed higher sensitivity than FISH (41.0% vs. 31.8%) with specificity of 100.0% vs. 96.9%. Discordant MFC/FISH cases showed subtype‐associated patterns, with MFC−/FISH+ findings more frequently observed in cases with numerical chromosomal abnormalities (e.g., hyperdiploidy) and immunophenotypic features resembling hematogones. Immunophenotypic marker expression varied by subtype, with near absence of CD10 in KMT2A ‐rearranged B‐ALL and increased CD81 expression in TCF3::PBX1 cases. MRD positivity by any method was associated with significantly worse relapse‐free survival. MFC, FISH, and NGS demonstrate complementary but variable performance in MRD detection across B‐ALL subtypes. Immunophenotypic and cytogenetic heterogeneity influence the sensitivity of individual modalities, supporting the use of an integrated, multimodal approach for MRD surveillance.

Schlagwörter

Stichwörter der Autor:innen

B‐lymphoblastic leukemiafluorescence in situ hybridizationmeasurable residual diseasemultiparametric flow cytometrynext‐generation sequencing

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Laboratory Medicine, National Fire Hospital, Eumsung, Republic of Korea.
  • Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

ORCID-Profile: Ju-Hyeong Lee, Tae-Shin Kim, Sang Mee Hwang, Hyungsuk Kim, Yoon Hwan Chang, Hyun Kyung Kim, Seon Young Kim

Förderung

  • SNUH Research Fund
  • Korean Society of Hematology

Zitieren

APA

Lee, J. H., Kim, T. S., Hwang, S. M., Kim, H., Chang, Y. H., Kim, H. K., & Kim, S. Y. (2026). Subtype‐specific immunophenotypic and cytogenetic patterns complement flow‐cytometric detection of measurable residual disease in B‐lymphoblastic leukemia. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.70062

Vancouver

Lee JH, Kim TS, Hwang SM, Kim H, Chang YH, Kim HK, et al. Subtype‐specific immunophenotypic and cytogenetic patterns complement flow‐cytometric detection of measurable residual disease in B‐lymphoblastic leukemia. Cytometry Part B: Clinical Cytometry. 2026. doi:10.1002/cyto.b.70062

BibTeX
@article{Lee2026,
  author = {Lee, Ju-Hyeong and Kim, Tae-Shin and Hwang, Sang Mee and Kim, Hyungsuk and Chang, Yoon Hwan and Kim, Hyun Kyung and Kim, Seon Young},
  title = {Subtype‐specific immunophenotypic and cytogenetic patterns complement flow‐cytometric detection of measurable residual disease in B‐lymphoblastic leukemia},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2026},
  doi = {10.1002/cyto.b.70062}
}
Kostenlos starten →